Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 43Squamous Cell Carcinoma of Head and Neck 12Rectal Neoplasms 12Colonic Neoplasms 12Neoplasm Metastasis 9Head and Neck Neoplasms 8Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Colorectal Cancer Metastatic 3Carcinoma, Non-Small-Cell Lung 3Carcinoma 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Carcinoma, Squamous Cell 2mCRC 1Stomach Neoplasms 1Skin Neoplasms 1Recurrence 1Neoplasms, Unknown Primary 1Nasopharyngeal Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Liver Metastasis Colon Cancer 1Incurable Colorectal Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1

Interventions

Bevacizumab 2Oxaliplatin 1IFL protocol 1FOLFOXIRI protocol 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Liver Metastasis Colon Cancer × Cetuximab × Clear all
NCT04832776 2021-04-06

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

Fudan University

Phase 2 Unknown
160 enrolled
Gastrointestinal

Liver Metastasis Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡